Supplementary Methods
Phylogenetic hypothesis. Although previous studies have used various DNA markers, we found that the plastid marker ndhF, as well as the nuclear ITS were the ones that have been extensively sampled across subgenera. However, high divergence of ITS sequences within Euphorbia created a high level of alignment ambiguity at the genus level. Therefore, we based our phylogenetic analysis only on the ndhF sequence data. Sequences were aligned using MAFFT Version 7.205 1 with default parameters and subsequent manual adjustments were made in Mesquite Version 3.01
2 . Indels were in triplets apart from autapomorphic indels in certain sequences and in non-protein coding parts of the sequence. The nucleotide substitution model was determined in jModelTest version 2.1.7 3, 4 . Using the Akaike Information Criterion 5 (AIC) GTR + I + G was selected as best model. Bayesian MCMC analyses 6 were performed using MrBayes version 3.2.5 7 . Two concurrent runs of 4 chains of 1 x 10 7 generations were executed, sampling every 500 generations. Examination of the trace files in Tracer 1.6.0 8 demonstrated convergence of the runs and the average standard deviation of split frequencies in MrBayes reached a value below 0.007. Tracer was also used to ensure an effective sample size of > 200 for all parameters. The plot of the log likelihood values in Tracer indicated a relative burn-in period of 10%. Therefore, the first 10% of the trees from each run were disregarded when computing the consensus tree in MrBayes.
Medicinal uses of species of the genus Euphorbia. In all phylogenetic manipulations, information below the species rank was not taken into account (all relevant information was merged at the species rank). Species in the phylogenetic tree with no record in the database 9 were scored as having no use (assigning 0 as the binary trait in the data matrix). Identifying Euphorbia uses modulating an inflammatory response. A use record in our database 9 was allocated to the inflammatory response category if either present treatment methods could likely mediate an inflammatory response or if the symptom of the disease for which the plant species is used could be associated to an inflammatory response. Species were assigned to the inflammatory response category, when at least one of their described uses in the database 9 could be linked to an inflammatory response. Evolutionary patterns of medicinal properties in Euphorbia. The D statistic is independent of tree size and trait prevalence (number of species in one category divided by the total number of species in the tree) if the tree has at least 50 terminals 10 . Our tree of 560 species therefore allowed the assumption of an unbiased estimate for D. However, cases of extremely low prevalence (e.g. 0.02 and under, or up to 8 species in a category in our study) have not been tested by Fritz and Purvis 10 . For our study, we considered categories with prevalence below 0.02 as potentially biased and therefore did not include them in any analysis. All comparative analyses were performed on phylograms with branch lengths proportional to DNA changes. Trees were only made ultrametric using the chronopl function in the R package ape 11 after statistical analyses for visualization purposes. Additional to the R packages mentioned in the main text also geiger 12 and plyr 13 were used. For graphical representation the tree drawing tool FigTree Version 1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/) as well as the R environment extended by corresponding packages were used. (1) oedemas (1) possible Mammals humans (126) Digestive System Disorders (12) purgative (4) no Mammals humans (126) Digestive System Disorders (12) emetic (2) no Mammals humans (126) Digestive System Disorders (12) vomiting (1) no Mammals humans (126) Digestive System Disorders (12) diarrhoea (1) no Mammals humans (126) Digestive System Disorders (12) death (2) no Mammals humans (126) Digestive System Disorders (12) weight loss (1) no Mammals humans (126) Digestive System Disorders (12) milk sickness (1) no Mammals humans (126) Genitourinary System Disorders (1) renal damage (1) no Mammals humans (126) Inflammation (7) possible Mammals humans (126) Injuries (10) haemorrhages (2) no Mammals humans (126) Injuries (10) blisters (8) possible Mammals humans (126) Mental Disorders (1) delirium (1) no Mammals humans (126) Pain (1) possible Mammals humans (126) Pregnancy/Birth/Puerperium Disorders (2) abortifacient (2) no Mammals humans (126) Sensory System Disorders (11) blindness (9) no Mammals humans (126) Sensory System Disorders (11) unspecified ( Mental Disorders (7) hallucinogenic (1) no Mental Disorders (7) narcotic (1) no Mental Disorders (7) alcohol dependence (3) no Mental Disorders (7) sleep disorders, hypnotic (1) no Mental Disorders (7) unspecified ( Nervous System Disorders (7) paralysis (2) no Nervous System Disorders (7) unspecified (1) unknown Nutritional Disorders (10) malnutrition (1) no Nutritional Disorders (10) tonic ( 
